Status:
COMPLETED
Development of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Posterior Cortical Atrophy
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the spatial location of objects, their manipulation and/or recognition. Its etiology is most often neurodegenerative...
Eligibility Criteria
Inclusion
- Age \>50 years old
- Male or Female
- Patients with a diagnosis of PCA according to the criteria of Tang-Wai et al (2004)
- MMS\>15
- Voluntary, written and informed consent of the patient himself or its legal representative (guardian/curator), with oral consent of the patient in all cases
- Anti-Alzheimer's and psychotropic treatments stable for one month, if taken by the patient
- Affiliation to a social security system
Exclusion
- Uncorrected visual disorders with non-degenerative etiology (AV\<0.5)
- Person under the protection of justice
- Pregnant women (a pregnancy test will be performed in premenopausal women)
Key Trial Info
Start Date :
September 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04041089
Start Date
September 2 2019
End Date
June 15 2022
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Claude Pompidou - Centre Mémoire de Ressources et de Recherche du CHU de Nice
Nice, Alpes-Maritime, France, 06100